Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Capital Reinvestment Ratio
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Capital Reinvestment Ratio of 0.28x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥116.38 Million) in capital expenditures (CN¥33.16 Million). Check how tangible is Medprin Regenerative Medical Technologie's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medprin Regenerative Medical Technologies Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Medprin Regenerative Medical Technologies Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Medprin Regenerative Medical Technologie generate cash.
Annual Capital Reinvestment Ratio for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024. See Medprin Regenerative Medical Technologie free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | CN¥116.38 Million | CN¥33.16 Million | ▼ -23.5% |
| 2023 | 0.37x | CN¥107.69 Million | CN¥40.09 Million | ▼ -86.8% |
| 2022 | 2.81x | CN¥48.31 Million | CN¥135.96 Million | ▲ +22.6% |
| 2021 | 2.30x | CN¥66.51 Million | CN¥152.71 Million | ▲ +26.3% |
| 2020 | 1.82x | CN¥33.91 Million | CN¥61.65 Million | ▲ +54.9% |
| 2019 | 1.17x | CN¥31.27 Million | CN¥36.71 Million | — |